Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.00
12.90 (1.40%) Zydus Lifesciences informs about press release
Date: 22-01-2026Zydus Lifesciences has informed that it enclosed a copy of press release dated January 22, 2026, titled ‘Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha™’, in India to treat multiple cancers’.
The above information is a part of company’s filings submitted to BSE.